COVID-19 Prevention and Management : Overview

Authors

  • Dr. P. Srilatha Reddy  Former Research Scholar, Institute of Science and Technology, Jawaharlal Nehru Technological University Hyderabad, Kukatpally, Hyderabad, Telangana, India

DOI:

https://doi.org/10.32628/IJSRST20761

Keywords:

Coronavirus, COVID-19, Prevention and Management, Contagious Respiratory, Vascular Disease, Severe Acute Respiratory Syndrome Coronavirus

Abstract

COVID-19 was originated from Wuhan city of Hubei Province in China in December 2019. Since then it has spread to more than 216 countries and territories. It is a contagious respiratory and vascular disease due to the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) a specific type of coronavirus. The patients show common symptoms like cough, sore throat, fever, breathing problems, and loss of smell and taste. The disease due to SARS-CoV-2 was named COVID-19. COVID-19 mainly spreads through the air when people are near each other, primarily via small droplets or aerosols, as an infected person breathe, coughs, sneezes and speaks. About 46.8 million people have been infected with more than 1.2 million deaths globally. The United States of America is the most affected country with the highest patients of about 9.47million. In spite of immense efforts, there is no treatment of this disease. However, prevention and management are the best options. This article describes SARS-CoV-2, disease, symptoms, transmission, diagnosis, prevention and management. It is immediately advised and requested that all humankind should follow the precautionary measures and managements to stop Coronavirus spread otherwise the condition may be worsen. In particular, we focus on proper prevention and management is essential to combat this disease and there is a vital prerequisite to educate our novel generation for science and technology to fight against the COVID-19, this overview represents a picture of the current state of the art. It may be useful to create awareness among the community to prevent and manage COVID-19.

References

  1. Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry RF (April 2020). "The proximal origin of SARS-CoV-2". Nature Medicine. 26 (4): 450–452. doi:1038/s41591-020-0820-9. PMC7095063. PMID 32284615
  2. Berger K (12 March 2020). "The Man Who Saw the Pandemic Coming". Nautilus. Archivedfrom the original on 15 March 2020. Retrieved 16 March 2020.
  3. Wu YC, Chen CS, Chan YJ (March 2020). "The outbreak of COVID-19: An overview". Journal of the Chinese Medical Association. 83 (3): 217–220. doi:1097/JCMA.0000000000000270. PMC7153464. PMID 32134861.
  4. Wang C, Horby PW, Hayden FG, Gao GF (February 2020). "A novel coronavirus outbreak of global health concern". Lancet. 395 (10223): 470–473. doi:1016/S0140-6736(20)30185-9. PMC7135038. PMID 31986257.
  5. Cohen J (January 2020). "Wuhan seafood market may not be source of novel virus spreading globally". Science. doi:1126/science.abb0611.
  6. "Novel Coronavirus – China". World Health Organization(WHO). 12 January 2020.
  7. Kessler G (17 April 2020). "Trump's false claim that the WHO said the coronavirus was 'not communicable'". The Washington Post. Archivedfrom the original on 17 April 2020. Retrieved 17 April 2020.
  8. Kuo L (21 January 2020). "China confirms human-to-human transmission of coronavirus". The Guardian. Retrieved 18 April 2020.
  9. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. (March 2020). "Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia". New England Journal of Medicine. 382 (13): 1199–1207. doi:1056/NEJMoa2001316. PMC7121484. PMID 31995857.
  10. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19)(PDF) (Report). World Health Organization (WHO). 24 February 2020. Archived (PDF) from the original on 29 February 2020. Retrieved 21 March2020.
  11. China confirms sharp rise in cases of SARS-like virus across the country". 20 January 2020. Archivedfrom the original on 20 January 2020. Retrieved 20 January 2020
  12. The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team (17 February 2020). "The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) – China, 2020". China CDC Weekly. 2 (8): 113–122. doi:46234/ccdcw2020.032. Retrieved 18 March 2020.
  13. Jump up to:ab "Flattery and foot dragging: China's influence over the WHO under scrutiny". The Globe and Mail. 25 April 2020
  14. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. (24 January 2020). "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China". Lancet. 395 (10223): 497–506. doi:1016/S0140-6736(20)30183-5. PMC7159299. PMID 31986264.
  15. Horton, Richard(18 March 2020). "Scientists have been sounding the alarm on coronavirus for months. Why did Britain fail to act?". The Guardian. Retrieved 23 April 2020
  16. Jump up to:ab "Flattery and foot dragging: China's influence over the WHO under scrutiny". The Globe and Mail. 25 April 2020.
  17. China delayed releasing coronavirus info, frustrating WHO". AP NEWS. 2 June 2020. Retrieved 3 June2020
  18. S. Centers for Disease Control and Prevention (CDC).Coronavirus types.
  19. Perlman, S.; Netland, J. Coronaviruses post-SARS: Update on replication and pathogenesis. Nat. Rev. Microbiol. 2009, 7, 439–450. [Google Scholar] [CrossRef] [PubMed]
  20. Lu, R.; Zhao, X.; Li, J.; Niu, P.; Yang, B.; Wu, H.; Wang, W.; Song, H.; Huang, B.; Zhu, N.; et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. Lancet 2020, 395, 565–574. [Google Scholar] [CrossRef]
  21. Yin, Y.; Wunderink, R.G. MERS, SARS and other coronaviruses as causes of pneumonia. Respirology 2018, 23, 130–137. [Google Scholar] [CrossRef]
  22. Phan, T. Novel coronavirus: From discovery to clinical diagnostics. Infect. Genet. Evol. 2020, 79. [Google Scholar] [CrossRef]
  23. Grant MC, Geoghegan L, Arbyn M, Mohammed Z, McGuinness L, Clarke EL, Wade RG (23 June 2020). "The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): A systematic review and meta-analysis of 148 studies from 9 countries". PLOS ONE. 15 (6): Bibcode:2020PLoSO..1534765G. doi:10.1371/journal.pone.0234765. PMC 7310678. PMID 32574165. S2CID 220046286.
  24. "Symptoms of Coronavirus". U.S. Centers for Disease Control and Prevention (CDC). 13 May 2020. Archivedfrom the original on 17 June 2020. Retrieved 18 June 2020.
  25. Bénézit, François; Le Turnier, Paul; Declerck, Charles; Paillé, Cécile; Revest, Matthieu; Dubée, Vincent; Tattevin, Pierre (2020). "Utility of hyposmia and hypogeusia for the diagnosis of COVID-19". The Lancet Infectious Diseases. 20 (9): 1014–1015. doi:1016/S1473-3099(20)30297-8. PMID32304632. S2CID 215769604.
  26. "Coronavirus". World Health Organization(WHO). Retrieved 4 May 2020.
  27. Jump up to:ab "Symptoms of Coronavirus". U.S. Centers for Disease Control and Prevention (CDC). 20 March 2020. Archived from the original on 30 January 2020.
  28. Jump up to:ab Gandhi RT, Lynch JB, Del Rio C (April 2020). "Mild or Moderate Covid-19". The New England Journal of Medicine. doi:1056/NEJMcp2009249. PMID 32329974.
  29. Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC (August 2020). "Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review". JAMA. 324 (8): 782–793. doi:1001/jama.2020.12839. PMID32648899. S2CID 220465311
  30. "COVID-19: epidemiology, virology and clinical features". GOV.UK. Retrieved 18 October 2020.
  31. "Q&A: How is COVID-19 transmitted? (How is the virus that causes COVID-19 most commonly transmitted between people?)". who.int. 9 July 2020. Retrieved 14 October 2020.
  32. Jump up to:ab c d e "Transmission of COVID-19". ecdc.europa.eu. 7 September 2020. Retrieved 14 October 2020.
  33. "Frequently Asked Questions (Spread)". cdc.gov. 9 October 2020. Retrieved 14 October 2020.
  34. Jump up to:ab c "Q&A: How is COVID-19 transmitted? (What do we know about aerosol transmission?)". who.int. 9 July 2020. Retrieved 14 October 2020.
  35. Jayaweera, M.; Perera, H.; Gunawardana, B.; Manatunge, J. (2020). "Transmission of COVID-19 virus by droplets and aerosols: A critical review on the unresolved dichotomy". Environmental Research. 188: 109819. Bibcode:...188j9819J. doi:10.1016/j.envres.2020.109819. PMC7293495. PMID 32569870.
  36. Jump up to:ab Kohanski, Michael A.; Lo, L. James; Waring, Michael S. (2020). "Review of indoor aerosol generation, transport, and control in the context of COVID-19". International Forum of Allergy & Rhinology. n/a (n/a): 1173–1179. doi:1002/alr.22661. ISSN 2042-6984. PMC 7405119. PMID 32652898.
  37. Jump up to:ab c d e "Transmission of SARS-CoV-2: implications for infection prevention precautions" (PDF). who.int. World Health Organization. 9 July 2020. Archived from the original on 9 July 2020. Retrieved 18 September 2020.
  38. Jump up to:ab "Water, sanitation, hygiene, and waste management for SARS-CoV-2, the virus that causes COVID-19" (PDF). who.int. 29 July 2020. Retrieved 14 October2020.
  39. Jump up to:ab Meyerowitz, Eric A.; Richterman, Aaron; Gandhi, Rajesh T.; Sax, Paul E. (17 September 2020). "Transmission of SARS-CoV-2: A Review of Viral, Host, and Environmental Factors". Annals of Internal Medicine. doi:7326/M20-5008. ISSN 0003-4819. PMC 7505025. PMID 32941052.
  40. Jump up to:ab c "Q & A on COVID-19: Basic facts". ecdc.europa.eu. 25 September 2020. Retrieved 8 October 2020.
  41. "How COVID-19 Spreads". cdc.gov. 5 October 2020. Retrieved 7 October2020.
  42. Liu, Tao; Gong, Dexin; Xiao, Jianpeng; Hu, Jianxiong; He, Guanhao; Rong, Zuhua; Ma, Wenjun (2020). "Cluster infections play important roles in the rapid evolution of COVID-19 transmission: A systematic review". International Journal of Infectious Diseases. 99: 374–380. doi:1016/j.ijid.2020.07.073. ISSN1201-9712. PMC 7405860. PMID 32768702.
  43. Herscher, Rebecca (12 October 2020). "Scientists Confirm Nevada Man Was Infected Twice With Coronavirus". NPR. Retrieved 12 October 2020.
  44. Tillet, Richard L.; et al. (12 October 2020). "Genomic evidence for reinfection with SARS-CoV-2: a case study". The Lancet. doi:1016/S1473-3099(20)30764-7. PMID33058797. S2CID 222295687. Retrieved 12 October 2020.
  45. "2019 Novel Coronavirus (2019-nCoV) Situation Summary". U.S. Centers for Disease Control and Prevention(CDC). 30 January 2020. Archived from the original on 26 January 2020. Retrieved 30 January 2020.
  46. "Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 (COVID-19)". U.S. Centers for Disease Control and Prevention(CDC). 11 February 2020. Archived from the original on 4 March 2020. Retrieved 26 March 2020.
  47. "Real-Time RT-PCR Panel for Detection 2019-nCoV". U.S. Centers for Disease Control and Prevention(CDC). 29 January 2020. Archived from the original on 30 January 2020. Retrieved 1 February 2020.
  48. "Curetis Group Company Ares Genetics and BGI Group Collaborate to Offer Next-Generation Sequencing and PCR-based Coronavirus (2019-nCoV) Testing in Europe". GlobeNewswire News Room. 30 January 2020. Archivedfrom the original on 31 January 2020. Retrieved 1 February 2020.
  49. Brueck H (30 January 2020). "There's only one way to know if you have the coronavirus, and it involves machines full of spit and mucus". Business Insider. Archivedfrom the original on 1 February 2020. Retrieved 1 February 2020.
  50. "Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases". Archivedfrom the original on 21 February 2020. Retrieved 26 February2020.
  51. Petherick A (April 2020). "Developing antibody tests for SARS-CoV-2". Lancet. 395 (10230): 1101–1102. doi:1016/s0140-6736(20)30788-1. PMC7270070. PMID 32247384.
  52. Vogel G (March 2020). "New blood tests for antibodies could show true scale of coronavirus pandemic". Science. doi:1126/science.abb8028.
  53. Pang J, Wang MX, Ang IY, Tan SH, Lewis RF, Chen JI, et al. (February 2020). "Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review". Journal of Clinical Medicine. 9 (3): 623. doi:3390/jcm9030623. PMC7141113. PMID 32110875.
  54. Deeks JJ, Dinnes J, Takwoingi Y, Davenport C, Spijker R, Taylor-Phillips S, et al. (June 2020). "Antibody tests for identification of current and past infection with SARS-CoV-2". The Cochrane Database of Systematic Reviews. 6: CD013652. doi:1002/14651858.CD013652. PMC7387103. PMID 32584464. S2CID 220061130.
  55. To KK, Tsang OT, Chik-Yan Yip C, Chan KH, Wu TC, Chan JM, et al. (February 2020). "Consistent detection of 2019 novel coronavirus in saliva". Clinical Infectious Diseases. Oxford University Press. 71 (15): 841–843. doi:1093/cid/ciaa149. PMC7108139. PMID 32047895.
  56. Salehi S, Abedi A, Balakrishnan S, Gholamrezanezhad A (March 2020). "Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 Patients". AJR. American Journal of Roentgenology. 215 (1):8793. doi:2214/AJR.20.23034. PMID32174129.
  57. "ACR Recommendations for the use of Chest Radiography and Computed Tomography (CT) for Suspected COVID-19 Infection". American College of Radiology. 22 March 2020. Archivedfrom the original on 28 March 2020.
  58. Pormohammad, A; Ghorbani, S; Khatami, A; Razizadeh, MH; Alborzi, E; Zarei, M; Idrovo, JP; Turner, RJ (9 October 2020). "Comparison of influenza type A and B with COVID-19: A global systematic review and meta-analysis on clinical, laboratory and radiographic findings". Reviews in Medical Virology: e2179. doi:1002/rmv.2179. PMID33035373. S2CID 222255245.
  59. Lee EY, Ng MY, Khong PL (April 2020). "COVID-19 pneumonia: what has CT taught us?". The Lancet. Infectious Diseases. 20 (4): 384–385. doi:1016/S1473-3099(20)30134-1. PMC7128449. PMID 32105641. Archived from the original on 8 March 2020. Retrieved 13 March 2020.
  60. https://en.wikipedia.org/wiki/Coronavirus_disease_2019
  61. "Recommendation Regarding the Use of Cloth Face Coverings, Especially in Areas of Significant Community-Based Transmission". U.S. Centers for Disease Control and Prevention(CDC). 28 June 2020.
  62. Jump up to:ab c Centers for Disease Control and Prevention (3 February 2020). "Coronavirus Disease 2019 (COVID-19): Prevention & Treatment". Archived from the original on 15 December 2019. Retrieved 10 February 2020.
  63. World Health Organization. "Advice for Public". Archivedfrom the original on 26 January 2020. Retrieved 10 February 2020.
  64. "My Hand-Washing Song: Readers Offer Lyrics for A 20-Second Scrub". NPR.org. Archivedfrom the original on 20 March 2020. Retrieved 20 March 2020.
  65. Jump up to:ab Centers for Disease Control and Prevention (5 April 2020). "What to Do if You Are Sick". U.S. Centers for Disease Control and Prevention (CDC). Archived from the original on 14 February 2020. Retrieved 24 April 2020.
  66. "Coronavirus Disease 2019 (COVID-19) – Prevention & Treatment". U.S. Centers for Disease Control and Prevention(CDC). 10 March 2020. Archived from the original on 11 March 2020. Retrieved 11 March 2020.
  67. Verbeek JH, Rajamaki B, Ijaz S, Sauni R, Toomey E, Blackwood B, et al. (May 2020). "Personal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff". The Cochrane Database of Systematic Reviews. 5: CD011621. 
  68. "Wear masks in public says WHO, in update of COVID-19 advice". Reuters. 5 June 2020. Retrieved 3 July 2020.
  69. Jump up to:ab c "Recommendations for Cloth Face Covers". U.S. Centers for Disease Control and Prevention (CDC). 3 April 2020. Retrieved 3 June 2020.
  70. "When and how to use masks". WHO. Retrieved 3 July 2020.
  71. Jump up to:ab c d "Social distancing: what you need to do – Coronavirus (COVID-19)". nhs.uk. 2 June 2020. Retrieved 18 August 2020.
  72. "COVID-19: Use of masks in the community". Ministry of Health NZ. Retrieved 18 August 2020.
  73. "Caring for Someone Sick at Home". U.S. Centers for Disease Control and Prevention(CDC). 11 February 2020. Retrieved 3 July 2020.
  74. Maragakis LL. "Coronavirus, Social Distancing and Self Quarantine". www.hopkinsmedicine.org. Johns Hopkins University. Archivedfrom the original on 18 March 2020. Retrieved 18 March 2020.
  75. Parker-Pope T(19 March 2020). "Deciding How Much Distance You Should Keep". The New York Times. ISSN 0362-4331. Archived from the original on 20 March 2020. Retrieved 20 March 2020.
  76. Systrom K, Krieger M, O'Rourke R, Stein R, Dellaert F, Lerer A (11 April 2020). "RtCovid-19". rt.live. Retrieved 19 April 2020. Based on Bettencourt LM, Ribeiro RM (May 2008). "Real time bayesian estimation of the epidemic potential of emerging infectious diseases". PLOS ONE. 3 (5): e2185. Bibcode:..3.2185B. doi:10.1371/journal.pone.0002185. PMC2366072. PMID 18478118.
  77. Centers for Disease Control and Prevention(3 February 2020). "Coronavirus Disease 2019 (COVID-19): Prevention & Treatment". Archived from the original on 15 December 2019. Retrieved 10 February 2020.
  78. "Social distancing: what you need to do – Coronavirus (COVID-19)". nhs.uk. 2 June 2020. Retrieved 18 August2020.
  79. "WHO-recommended hand rub formulations". WHO Guidelines on Hand Hygiene in Health Care: First Global Patient Safety Challenge Clean Care Is Safer Care. World Health Organization. 19 March 2009. Retrieved 19 March2020.
  80. Fisher D, Heymann D (February 2020). "Q&A: The novel coronavirus outbreak causing COVID-19". BMC Medicine. 18 (1): 57. doi:1186/s12916-020-01533-w. PMC7047369. PMID 32106852.
  81. Liu K, Fang YY, Deng Y, Liu W, Wang MF, Ma JP, et al. (May 2020). "Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province". Chinese Medical Journal. 133 (9): 1025–1031. doi:1097/CM9.0000000000000744. PMC7147277. PMID 32044814.
  82. Wang T, Du Z, Zhu F, Cao Z, An Y, Gao Y, Jiang B (March 2020). "Comorbidities and multi-organ injuries in the treatment of COVID-19". Lancet. 395 (10228): e52. doi:1016/s0140-6736(20)30558-4. PMC7270177. PMID 32171074.
  83. Henry BM (April 2020). "COVID-19, ECMO, and lymphopenia: a word of caution". The Lancet. Respiratory Medicine. 8 (4): e24. doi:1016/s2213-2600(20)30119-3. PMC7118650. PMID 32178774.
  84. Wang L, Wang Y, Ye D, Liu Q (March 2020). "Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence". International Journal of AntimicrobialAgents. 55 (6):105948. doi:1016/j.ijantimicag.2020.105948. PMC7156162. PMID 32201353. Archived from the original on 27 March 2020. Retrieved 27 March 2020.
  85. Wang Y, Wang Y, Chen Y, Qin Q (March 2020). "Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures". Journal of Medical Virology. n/a (n/a): 568–576. doi:1002/jmv.25748. PMC7228347. PMID 32134116
  86. Ali, Imran, and Omar M L Alharbi. “COVID-19: Disease, management, treatment, and social impact.” The Science of the total environment vol. 728 (2020): 138861. doi:10.1016/j.scitotenv.2020.138861
  87. Centers for Disease Control and Prevention https://www.cdc.gov/coronavirus/types.html
  88. Di Gennaro F, Pizzol D, Marotta C, Antunes M, Racalbuto V, Veronese N, Smith L. Coronavirus Diseases (COVID-19) Current Status and Future Perspectives: A Narrative Review. Int J Environ Res Public Health. 2020 Apr 14; 17(8):2690. doi: 10.3390/ijerph17082690. PMID: 32295188; PMCID: PMC7215977.

International Journal of Scientific Research in Science and Technology

Downloads

Published

2020-12-30

Issue

Volume 7, Issue 6, November-December-2020

Section

Research Articles

License

Copyright (c) IJSRST

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

[1]
Dr. P. Srilatha Reddy "COVID-19 Prevention and Management : Overview" International Journal of Scientific Research in Science and Technology(IJSRST), Online ISSN : 2395-602X, Print ISSN : 2395-6011,Volume 7, Issue 6, pp.23-32, November-December-2020. Available at doi : https://doi.org/10.32628/IJSRST20761